According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ10.05. In 2022 the company made an earnings per share (EPS) of -ยฃ10.05 an increase over its 2021 EPS that were of -ยฃ14.11.